Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.41% |
| 2 | Financials | 12.33% |
| 3 | Energy | 10.93% |
| 4 | Industrials | 10.41% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Titan International
TWI
$449M
| $2.82M | 0.01% |
251,338
+40,563
| +19% | +$444K |
|
|
DNR
1677
DELISTED
Denbury Resources, Inc.
DNR
| $2.81M | 0.01% |
764,596
-1,411,886
| -65% | -$4.54M |
|
1678
Independent Bank Corp
IBCP
$812M
| $2.81M | 0.01% |
129,606
+44,550
| +52% | +$822K |
|
1679
Truist Financial
TFC
$61.5B
| $2.78M | 0.01% |
+59,165
| New | +$2.52M |
|
|
SPNE
1680
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $2.78M | 0.01% |
351,754
-45,169
| -11% | -$381K |
|
|
MYCC
1681
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $2.78M | 0.01% |
193,492
-226,423
| -54% | -$3.01M |
|
|
OSB
1682
DELISTED
Norbord Inc.
OSB
| $2.78M | 0.01% |
109,946
-24,487
| -18% | -$610K |
|
1683
Harmony Gold Mining
HMY
$13.2B
| $2.77M | 0.01% |
1,251,751
+512,838
| +69% | +$1.36M |
|
1684
CALL
Puma Biotechnology
PBYI
$474M
| $2.76M | 0.01% |
+90,000
| New | +$3.89M |
|
1685
First Commonwealth Financial
FCF
$2.1B
| $2.76M | 0.01% |
+194,595
| New | +$2.27M |
|
1686
Carlyle Group
CG
$17.8B
| $2.75M | 0.01% |
+180,505
| New | +$2.79M |
|
|
BBBY
1687
DELISTED
Bed Bath & Beyond Inc
BBBY
| $2.75M | 0.01% |
67,717
-141,956
| -68% | -$6.16M |
|
|
ANH
1688
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $2.75M | 0.01% |
532,007
+63,793
| +14% | +$322K |
|
|
CPN
1689
DELISTED
Calpine Corporation
CPN
| $2.75M | 0.01% |
240,342
-188,735
| -44% | -$2.23M |
|
|
INFO
1690
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $2.74M | 0.01% |
+77,495
| New | +$2.78M |
|
1691
CALL
Sarepta Therapeutics
SRPT
$2.2B
| $2.74M | 0.01% |
100,000
-74,700
| -43% | -$3M |
|
1692
CALL
Ashland
ASH
$3.39B
| $2.73M | 0.01% |
+51,100
| New | +$2.81M |
|
1693
Vanguard Total Bond Market
BND
$162B
| $2.73M | 0.01% |
33,784
-13,474
| -29% | -$1.1M |
|
|
BAS
1694
DELISTED
Basis Energy Services, Inc.
BAS
| $2.73M | 0.01% |
77,121
+76,580
| +14,155% | +$20.8M |
|
1695
Xencor
XNCR
$2.1B
| $2.72M | 0.01% |
103,387
+72,210
| +232% | +$1.74M |
|
|
ADAP
1696
DELISTED
Adaptimmune Therapeutics
ADAP
| $2.72M | 0.01% |
671,660
+25,170
| +4% | +$121K |
|
1697
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$297M
| $2.72M | 0.01% |
66,530
+16,530
| +33% | +$624K |
|
1698
LeMaitre Vascular
LMAT
$1.82B
| $2.71M | 0.01% |
107,132
-98,181
| -48% | -$2.18M |
|
1699
HCA Healthcare
HCA
$91.8B
| $2.71M | 0.01% |
36,593
-212,271
| -85% | -$15.9M |
|
|
HAPN
1700
Happen Inc
HAPN
$2.12B
| $2.71M | 0.01% |
+103,109
| New | +$2.83M |
|
Similar funds
Israel Englander's Q4 2016 Portfolio in Review
As of Q4 2016, Israel Englander held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Israel Englander withdrew a net $7.71B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Energy.
Against the trend, Israel Englander opened a new position in Target worth $175M.
- Israel Englander's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Israel Englander added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Israel Englander's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Israel Englander fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Israel Englander's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Israel Englander opened 858 new positions and closed 801 in Q4 2016.
- Israel Englander's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.